Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
2 Nov 2026
Long COVID Risk Higher with Autoimmune Rheumatic Diseases
Autoimmune rheumatic diseases have been linked to a higher risk of Long COVID, with certain therapies and clinical factors also linked.
2 Nov 2026
Mucous Membrane Pemphigoid Shows Site-Specific Remission Patterns
Multisite mucous membrane pemphigoid: only 45% achieved complete remission, with oral and ocular disease limiting treatment success.
2 Nov 2026
Metabolomic Profiles in Multiple Sclerosis Linked to Disease Severity
Gut-derived metabolites have been linked to greater disease severity in multiple sclerosis. Learn how metabolomic profiles could guide biomarker research.
2 Nov 2026
IL-33 Inhibition Reduces COPD Exacerbations in Phase III Trials
Two Phase III trials involving 1,750 COPD patients found that IL-33 inhibition reduced moderate-to-severe exacerbation rates by 29–34% over 52 weeks.
2 Nov 2026
Cash-Only Dermatology Sparks Debate Over Equitable Care
Cash-only dermatology practices offer physicians greater autonomy but raise ethical concerns about equitable access to care.
2 Nov 2026
Vagus Nerve Stimulation Therapy™ in Drug-Resistant Epilepsy
Navigate a case study of a patient with drug-resistant epilepsy, exploring presentation, refractory symptoms, and conversations…
6
Mins
2 Nov 2026
Regulatory Science: A Condition of Innovation for AI as a Medical Device
The existing framework is built for stable, predictable products with well-established pre-market risk clarity…
6
Mins
2 Nov 2026
Autoinflammation vs. Infection in VEXAS Syndrome
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an adult-onset autoinflammatory disorder caused by somatic…
8
Mins
2 Nov 2026
Interview with Walter Maksymowych
When I started doing research in axial spondyloarthritis (axSpA), I realized that I needed an objective way of documenting…
1 Nov 2026
CRISPR Screens Reveal New Genes Regulating Red Blood Cell Density
CRISPR screens identified 17 genes and 13 genomic regions linked to red blood cell density, providing new insights into how genetic variants influence red blood cell traits.
←
1
2
3
…
28
29
30
31
32
33
34
…
1,854
1,855
1,856
→
We’ve noticed you’re accessing
from
North/South America.
View
View